Carson Wealth (CWM LLC)’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47K | Buy |
2,666
+155
| +6% | +$2.73K | ﹤0.01% | 3329 |
|
|
2025
Q1 | $45K | Buy |
2,511
+40
| +2% | +$717 | ﹤0.01% | 3060 |
|
|
2024
Q4 | $74K | Buy |
2,471
+315
| +15% | +$9.43K | ﹤0.01% | 2490 |
|
|
2024
Q3 | $34K | Sell |
2,156
-3,125
| -59% | -$49.3K | ﹤0.01% | 2993 |
|
|
2024
Q2 | $90K | Buy |
5,281
+3,410
| +182% | +$58.1K | ﹤0.01% | 2033 |
|
|
2024
Q1 | $29K | Buy |
1,871
+116
| +7% | +$1.8K | ﹤0.01% | 2656 |
|
|
2023
Q4 | $26K | Sell |
1,755
-2,136
| -55% | -$31.6K | ﹤0.01% | 2598 |
|
|
2023
Q3 | $63K | Buy |
3,891
+2,184
| +128% | +$35.4K | ﹤0.01% | 1930 |
|
|
2023
Q2 | $71K | Sell |
1,707
-344
| -17% | -$14.3K | ﹤0.01% | 1763 |
|
|
2023
Q1 | $123K | Sell |
2,051
-28
| -1% | -$1.68K | ﹤0.01% | 1384 |
|
|
2022
Q4 | $152K | Buy |
2,079
+238
| +13% | +$17.4K | ﹤0.01% | 1202 |
|
|
2022
Q3 | $140K | Buy |
1,841
+92
| +5% | +$7K | ﹤0.01% | 1186 |
|
|
2022
Q2 | $122K | Buy |
1,749
+133
| +8% | +$9.28K | ﹤0.01% | 1232 |
|
|
2022
Q1 | $134K | Buy |
1,616
+381
| +31% | +$31.6K | ﹤0.01% | 1208 |
|
|
2021
Q4 | $93K | Buy |
+1,235
| New | +$93K | ﹤0.01% | 1321 |
|
|
2021
Q2 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2021
Q1 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2020
Q4 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2020
Q3 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2020
Q2 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2020
Q1 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2019
Q4 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2019
Q3 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2019
Q2 | $306K | Hold |
1,381
| – | – | ﹤0.01% | 777 |
|
|
2019
Q1 | $306K | Sell |
1,381
-3,819
| -73% | -$846K | ﹤0.01% | 777 |
|
|
2018
Q4 | $174K | Hold |
5,200
| – | – | ﹤0.01% | 625 |
|
|
2018
Q3 | $272K | Hold |
5,200
| – | – | 0.01% | 459 |
|
|
2018
Q2 | $163K | Buy |
+5,200
| New | +$163K | 0.01% | 453 |
|